Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
  Pharmaceutical Technology Europe E-Alert
 
18 November 2014
IN THIS ISSUE
News
Webcasts
Events
About Us
 
 
Featured Content
Parenterals, Particulates, and Quality by Design
An apparent increase in the number of recalls due to particulate contamination has drawn the attention of the industry. As measures are taken by manufacturers to address these issues, one aspect is the implementation of quality by design to ensure consistent and robust quality. More...
 
Considerations in Developing Sublingual Tablets—An Overview
This review highlights relevant physicochemical drug properties and formulation design considerations critical to quality and performance of the sublingual tablets. More...
 
Top Stories
Germany Post AMNOG: Insights for BioPharma
Regulatory data from prospective clinical trials alone are just not enough to convince payers to provide a price premium for new products. The authors take a look at some of the recent developments in the German pharmaceutical market and strategies for sustainable success. More...
 
EMA Responds to Questions about Confidential Information
In response to a letter EMA received from the European Ombudsman on 27 Oct. 2014, the agency is clarifying its policy on commercially confidential information. More...
 
FDA Issues Warning Letter to Cadila Pharmaceuticals for CGMP Deviations
FDA has issued a warning letter to Cadila Pharmaceuticals Limited (Gujarat, India) for cGMP deviations in the manufacture of APIs. More...
 
Industry News
Catalent Acquires Micron Technologies, Adds Particle Engineering Capabilities to Portfolio
The addition of Micron Technologies’ particle engineering capabilities is part of Catalent’s strategy to expand its delivery technology offerings. More...
 
Celerion Expands Cell-Based Assays Capabilities in Global Bioanalytical Services
Celerion has expanded this capability to meet increasing demand for immunogenicity assessment for large molecule analysis and for immune monitoring assays in drug development. More...
 
Novasep and Nilsan Nishotech to Install Continuous Chromatography System at Laurus Labs
This is the first time Laurus Labs will use a continuous chromatography system at multi-ton scale for chiral molecule separation at its API manufacturing site in India. More...
 
GE Partners with Takeda to Develop Therapeutic Drugs for Liver Disease
Under the terms of the agreement, GE will provide Takeda with its diagnostic imaging technology to help develop diagnostic technologies and therapeutic drugs for liver diseases. More...
 
Seven Steps to Solving Tabletting and Tooling Problems—Step 3: Repair
Carrying on from our weekly column to help you eliminate a number of tablet manufacturing problems and tablet tooling failures with a simple seven-step tool-care process, we look at the third step, Repair. More...
 
Webcasts
Developing a Comprehensive Tool Kit for Microbial Identification
Tuesday, November 18, 2014 at 8 AM CET PST/ 11 AM EST/ 4 PM GMT/ 5 PM CET
Sponsored by Eurofins Lancaster Laboratories
 
Choosing the Proper Dissolution Method When Testing Solubilization Performance
On Demand
Sponsored by BASF
 
More Webcasts

Product/Service Profile
Alkermes
Dry blend tablet coating and encapsulation expertise
Alkermes Contract Pharma Services’ experience in dry blend tableting and encapsulation can provide you with expert solutions to fulfil your specific manufacturing needs.  With over 45 years’ experience, we are a proven, reliable, high quality, commercial manufacturer of choice for 7 of 10 top pharma companies worldwide. Read more

Reference Library

Pharmaceutical Technology presents its Process Analytical Technology resource guide combo
A compilation of informative, useful articles designed to help you meet the challenges of process analytical technology, be more efficient in testing, reduce over-processing, enhance consistency, and minimize rejects ... Click here

Contact Us

Click here to contact editorial.

Click here to contact sales.